References
- Widell A, Sundström G, Hansson BG, Moestrup T, Nordenfelt E. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients. Vox Sang 1991;60:28–33.
- Muñoz-Gómez R, García-Monzón C, García-Buey L, Lo Iacono O, Borgue MJ, García-Sánchez A, et al. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease. Eur J Gastroenterol Hepatol 1996;8:273–7.
- Tanaka H, Hiyama T, Tsukumi H, Okubo Y, Yamano H, Kitada A, et al. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994;5:409–13.
- Verbaan H, Widell A, Lindgren S, Lindmark B, Nordenfelt E, Eriksson S. Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period. J Int Med 1992;232:33–42.
- Hepner GW, Vesell ES. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)-aminopyrine. Ann Intern Med 1975;83:632–8.
- Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long-term follow-up of non-A, non-B (type C) posttransfusion hepatitis. J Hepatol 1992;16:273–81.
- Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993;Suppl:S13–6.
- Simonetti RG, Camma C, Fiorello F, Politi F, D’Amico G, Pagliaro L. Hepatocellular carcinoma—a worldwide problem and the major risk factors. Dig Dis Sci 1991;36:962–72.
- Yousef M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol 1992;27:812–6.
- Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240–3.
- Mattsson L, Weiland O, Glaumann H. Chronic non-A, non-B hepatitis developed after transfusion, illicit self-injections or sporadically. Outcome during long-term follow-up—a comparison. Liver 1989;9:120–7.
- Wejstål R, Hermodsson S, Norkrans G. Long-term follow-up of chronic hepatitis non-A, non-B—with special reference to hepatitis C. Liver 1991;11:143–8.
- Mattsson L, Sonnerbörg A, Weiland O. Outcome of acute asymptomatic non-A, non-B hepatitis: a 13-years follow-up study of hepatitis C virus markers. Liver 1993;13:274–8.
- Kaczynski J, Hansson G, Hermodsson S, Olsson R, Wallerstedt S. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area. Scand J Gastroenterol 1996;31:809–13.
- Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47–53.
- Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre. J Hepatol 1996;25:821–6.
- Alemy-Carreau M, Durbec J-P, Giordanella J, Rousseau S, Blanc G, Monges D, et al. Lack of interaction between hepatitis C virus and alcohol in the pathogenesis of cirrhosis. A statistical study. J Hepatol 1996;25:627–32.